Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling.
about
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastomaStrategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the ChallengesA Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue SarcomasGermline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.Meta-analysis of differentially expressed genes in osteosarcoma based on gene expression data.Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted.Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma.Disease progression and solid tumor survival: a transcriptome decoherence modelTranscriptome, methylome and genomic variations analysis of ectopic thyroid glands.Biological analysis of cancer specific microRNAs on function modeling in osteosarcoma.Reproducibility and concordance of differential DNA methylation and gene expression in cancer.Distinct functional patterns of gene promoter hypomethylation and hypermethylation in cancer genomesRecurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.The Role of RUNX2 in Osteosarcoma Oncogenesis.Modulation of the osteosarcoma expression phenotype by microRNAsDeciphering squamous cell carcinoma using multidimensional genomic approaches.Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.The genetics of osteosarcoma.Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motilityCorrelation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcomaChronic maternal protein deprivation in mice is associated with overexpression of the cohesin-mediator complex in liver of their offspring.BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cellsThe Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progressionMultiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell linesA Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell linesPrognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma.Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.Post-genomics of bone metabolic dysfunctions and neoplasias.Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor.Epigenetic alterations in osteosarcoma: promising targets.Categorization of cancer through genomic complexity could guide research and management strategies.Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3.Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcomaLong non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma.
P2860
Q21261286-444744EF-979E-4D00-AB1F-0A3C0B02C6D2Q26766390-B53FEEA6-272F-468F-A7FC-F8A1CA74E0EEQ26782842-2EB178FB-911D-47F3-95BC-A36EAD80177FQ30235105-4C5729C9-CC1C-4F9B-9375-902C3E544A34Q30836485-AE5C0172-EEFC-4233-8782-1E0EFF91A1C5Q33542986-2E0DF354-0D91-47A4-A91C-1F58F11D4858Q33577472-5229699E-1B72-42A2-9946-284DE626C4EAQ33623477-26C7DE22-350B-487E-85B5-0A0E25BAABA1Q33637105-8F19D255-EA24-4635-AD4D-CFDBA7C65B0DQ33728457-2E0DDB3B-8DD0-43B7-92BC-CB57C869DC7EQ33906169-C4E0E3C5-9DF5-4088-A0D7-98DE072CC81FQ34123835-D0C9A0E4-E5E6-47BB-9A23-479C124C3768Q34412798-D82D0A97-1C63-448F-8092-B65B8E6CBCB9Q34413741-5B2DAFD5-F634-4852-A727-854D87FFF908Q34423871-495DF638-FBDF-4AA6-90D9-E94F53D1C01DQ34469322-8F79B164-FFCF-4C40-B3EE-2B71C733DC37Q34475613-20286D3C-B318-4FD2-919C-2F0124F32D30Q34570006-259EA3CF-67BA-42CE-8C2C-A6BB44E3BEADQ34639086-8059D4EC-DD0B-4A8A-B096-85D7114DDAC2Q34989177-31C3767C-C268-455E-B92B-B43D72CF4F5EQ35065555-B5FC51AA-08FF-4DB0-A3BD-9AE7FC322E93Q35572534-BE9CBBAF-9CB5-4412-8BC8-162D87781424Q35574955-C9B8A82E-3793-4586-8456-F40007936652Q35770577-66610F2C-0F18-49D0-960F-A65AA295A66EQ36152246-501B885A-A015-4E3F-8C5A-6A6DBAC11FFDQ36203931-522AF257-0F40-498D-B2E9-0C86649BE8ABQ36438319-1A071EA5-59E3-4981-8089-39ED0D91C16CQ36617953-AFA791AF-1EB7-46FC-B2E3-DC8F8BFDA0BAQ36672392-E4EA9C79-C294-4BA8-B2E5-6A55063FCF10Q36746247-D66B7416-D2D4-499E-B1AD-F3360C83FD63Q36750689-A544F00C-4309-41A1-ABC1-37617217677FQ37975963-C90722B2-BA11-49D7-9DEA-3C737D1FCB76Q38084245-04C9D24F-9F48-499B-8DF2-D6F9F162E923Q38185555-BBE64365-8CA4-4AC3-8BFA-FF9C9EC4CBC2Q38416477-6A876787-43C5-4B10-8360-DABD87C16479Q38782691-0E0B7402-5D6D-4B6D-86F3-AD42340E2C23Q39246205-B1FB1CD0-E0E2-4D10-8762-7F9759D6B8A2Q39361463-5A23AFEA-9DFD-479A-B72C-D874248AB8A0Q39801788-37338B7B-138B-4846-9A1C-B5F9B4F63475Q41279778-C5AD3DB5-4929-4656-B8D0-DA944E0F3537
P2860
Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Identification of interactive ...... ntegrated molecular profiling.
@en
Identification of interactive ...... ntegrated molecular profiling.
@nl
type
label
Identification of interactive ...... ntegrated molecular profiling.
@en
Identification of interactive ...... ntegrated molecular profiling.
@nl
prefLabel
Identification of interactive ...... ntegrated molecular profiling.
@en
Identification of interactive ...... ntegrated molecular profiling.
@nl
P2093
P2860
P356
P1476
Identification of interactive ...... ntegrated molecular profiling.
@en
P2093
Bekim Sadikovic
Maisa Yoshimoto
Maria Zielenska
Paul Thorner
Susan Chilton-MacNeill
P2860
P304
P356
10.1093/HMG/DDP117
P577
2009-03-13T00:00:00Z